RecruitingEarly Phase 1NCT05546658

Effects of Psilocybin in Obsessive Compulsive Disorder


Sponsor

Johns Hopkins University

Enrollment

30 participants

Start Date

Nov 28, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study will test the feasibility, safety, and evidence for efficacy of psilocybin administration in participants with obsessive compulsive disorder (OCD). This will serve as a preliminary proof of concept study for future larger studies aimed to investigate the utility, cognitive mechanisms, and neural correlates of this intervention.


Eligibility

Min Age: 21 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing psilocybin (the active compound in "magic mushrooms") as a treatment for people with obsessive-compulsive disorder (OCD) that hasn't fully responded to previous treatments. Researchers are exploring whether a carefully supervised dose can reduce OCD symptoms. **You may be eligible if...** - You have been diagnosed with OCD for at least 1 year - Your OCD symptoms are at a moderate-to-severe level (Y-BOCS score of 18 or more) - You have tried at least one previous treatment (therapy or medication) for OCD - You are not currently on antidepressants (or can safely stop them) - You are considered low risk for suicide **You may NOT be eligible if...** - You have a personal or family history of psychosis, schizophrenia, or bipolar disorder - You have a history of serious heart or liver conditions - You are pregnant or breastfeeding - You have an active substance use disorder - You are currently taking antidepressants you cannot stop Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPsilocybin

Psilocybin administration under supportive conditions


Locations(1)

Johns Hopkins University School of Medicine

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05546658


Related Trials